TITLE

COMPANY SPOTLIGHT - COMPANY SPOTLIGHT - Cephalon

PUB. DATE
March 2008
SOURCE
PharmaWatch: CNS;Mar2008, Vol. 7 Issue 3, p17
SOURCE TYPE
Market Research Report
DOC. TYPE
Article
ABSTRACT
The article presents a corporate profile for Cephalon Inc., an international biopharmaceutical company engaged in the discovery, development and marketing of products. Its business segments cover the core therapeutics areas which include central nervous system disorders, pain, oncology and addiction. The company's most significant product is Provigil tablets which comprised approximately 43% of Cephalon's total consolidated net sales for the year 2006.
ACCESSION #
31602404

 

Related Articles

  • COMPANY SPOTLIGHT -- Cephalon.  // PharmaWatch: Monthly Review;Jan2008, Vol. 7 Issue 1, p35 

    The article discusses the services and operation of Cephalon Inc., a U.S. drug company. The firm is engaged in the development and marketing of drugs in four therapeutic areas including central nervous system (CNS) disorders, pain, cancer and addiction. The impressive performance of one of its...

  • Company Overview.  // Cephalon SWOT Analysis;Apr2006, p4 

    Presents an overview of Cephalon Inc., a biopharmaceutical company engaged in developing and marketing drugs. Revenues generated in fiscal year ended December 2005; Principal diseases targeted, including central nervous system disorders, pain, cancer and addiction.

  • SWOT Analysis.  // Cephalon SWOT Analysis;Apr2006, p5 

    Provides a business analysis of Cephalon Inc., a biopharmaceutical company engaged in developing and marketing drugs, focusing on its strengths, weaknesses, opportunities for improvement and threats to the company. Strengths, including benefits derived from its strong revenue growth, and robust...

  • COMPANY SPOTLIGHT -- Cephalon.  // PharmaWatch: Biotechnology;Jun2006, Vol. 5 Issue 6, p32 

    The article focuses on Cephalon Inc., a U.S.-based biopharmaceutical firm which manufactures products used in the treatment of sleep disorders, neurological and psychiatric disorders. The company recorder revenues of about $714.8 million in 2003 and has shown robust performance on almost all...

  • COMPANY SPOTLIGHT - Pfizer.  // PharmaWatch: Monthly Review;Aug2010, Vol. 9 Issue 8, p23 

    The article presents a corporate profile of biopharmaceutical company Pfizer Inc. The company develops, manufactures and markets branded prescription small molecule and biologic medicines, vaccines and consumer health products. It reorganized its businesses into two segments which are...

  • R&D Update.  // PharmaWatch: CNS;Feb2007, Vol. 6 Issue 2, p10 

    The article provides information related to drug development in the U.S. Targacept Inc. started its phase II trial of TC-2696 for the treatment of acute post-operative pain. Cephalon Inc. discovered from its new studies of pain drug Fentora that the onset of pain relief may be faster than the...

  • Cephalon SWOT Analysis.  // Cephalon SWOT Analysis;Apr2006, p1 

    Presents an overview of Cephalon Inc., a biopharmaceutical company engaged in developing and marketing drugs. Company overview, including revenues generated in fiscal year ended December 2005, services provided, and principal drugs; Key facts, including contact information; Analysis of the...

  • Other News To Note.  // BioWorld Today;3/25/2013, Vol. 24 Issue 56, p2 

    The article reports on developments related to global biopharmaceutical industry including the worldwide license provided by LinXis BV to APO-T BV for the use Lx linker technology, creation of a subsidiary of Deinove to accelerate its antibiotic development program and the resubmission of a drug...

  • A Time of Ferment for Biopharmaceutical Contract Manufacturing. Boswell, Clay // Chemical Market Reporter;03/12/2001, Vol. 259 Issue 11, pFR11 

    Focuses on the impact of advances in genomics and drug discovery technologies on contract biopharmaceutical manufacturing. Application of microbial fermentation in biopharmaceuticals manufacture; Advantages of microbial fermentation over mammalian cell culture; Cost of fermentation and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics